KIA
INSM icon

Knollwood Investment Advisory’s Insmed INSM Stock Holding History

Knollwood Investment Advisory’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,501
Closed -$245K – 288
2026
Q1 		$245K Hold
1,501
– – 0.02% 282
2025
Q4 		$261K Hold
1,501
– – 0.02% 297
2025
Q3 		$216K Buy
+1,501
New +$184K 0.02% 342

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Knollwood Investment Advisory's INSM Position: Q2 2026 in Review

Knollwood Investment Advisory sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,501 shares — an estimated $245K sold.

Knollwood Investment Advisory first reported a position in INSM in Q3 2025 and held it in 3 quarters. The position peaked at $261K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Knollwood Investment Advisory reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Knollwood Investment Advisory sold 1,501 Insmed shares in Q2 2026, an estimated $245K.
  • Knollwood Investment Advisory first reported a position in Insmed in Q3 2025 and held it in 3 quarters.
  • Knollwood Investment Advisory's Insmed position peaked at $261K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.